The South African Health Products Regulatory Authority has approved the use of the Sinovac Covid-19 vaccine.
However, under certain conditions.
The approval is under Section 21 of the Medicines and Related Substance Act.
Individuals between the ages of 18 and 59 years can use the vaccine.
There are two doses that are administered 14 to 28 days apart.
One of the conditions is that Sinovac must submit the final results of ongoing clinical studies.
It also needs to submit periodic safety updates.
The Sinovac vaccine has a provisional shelf life of 24 months.
More Stories
Power Cuts To Continue Into The Weekend – Eskom
Eskom Confirms Sabotage At Tutuka Power Station
We Listened To The People – Ramaphosa
NICD Reports 7 238 New COVID-19 Cases In SA
NICD Reports 8 179 New COVID-19 Cases In SA
Nersa Opposing Legal Bid To Overturn Decision To Grant Karpowership Licences
Gift Of The Givers Slams Government For KZN Slow Response
After Criticism, Mthethwa R22m Flag Project To Be Reviewed – Mthethwa
Health Department Opposes Challenge To New Regulations
Mthethwa Defends R22m Flag Project
Teffo Must Follow Proper Channels – Lamola
NICD Reports 5 096 New COVID-19 Cases In SA